about
Orexin A and B evoke noradrenaline release from rat cerebrocortical slicesSSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by alpha2-adrenoceptors.The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in ratsIdentification of an imidazoline binding protein: creatine kinase and an imidazoline-2 binding site.Modulation of stress by imidazoline binding sites: implications for psychiatric disorders.Management of schizophrenia: clinical experience with asenapine.Stress, norepinephrine and depression.Altered interictal saccadic reaction time in migraine: a cross-sectional study.Behavioural and physiological effects induced by an infusion of antisense to alpha(2D)-adrenoceptors in the rat.Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic.Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test.Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats.Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients.Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex.Interactions between imidazoline binding sites and dopamine levels in the rat nucleus accumbens.
P2860
Q28365383-9D681669-A4E0-4311-91E7-83F47F470C26Q34067137-26678BE6-037D-49FF-958F-DEEDFBF90064Q35029193-2DDEBC32-9E24-48D4-BF23-9926C565FABDQ36534965-169EE06F-748E-4040-B09C-7C10D07BE0E2Q37294224-5637441E-A4BB-4873-8BE0-C114350170CCQ37324414-31151291-29F0-446B-B769-36D460DD6D25Q38093729-B1618D3C-DFC7-48C1-8703-C3980C8448EDQ38777577-7AC6454B-6562-47A3-81F4-1400CA7AE8B1Q39630560-D52967CD-3205-4886-8AC4-6427200F4B2CQ43264182-A2661231-393F-4596-8CA9-72BCA9BB416CQ44359160-0657C3DE-9861-46AE-9125-B09D58089A95Q44372622-4B4A308A-630C-4EE1-9DA4-7E542BA08F22Q44858859-2F19196F-7742-4459-AA9F-3E7D24A407A6Q44983998-96B90293-6F63-43FB-BB19-4EF64983975DQ48270765-CAA72F77-3459-4C6D-BF7C-962F949BB447Q48693880-0C605E6C-5F95-4AD4-A84E-8ABC5792A6BC
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Noradrenergic mechanisms in the prefrontal cortex.
@en
type
label
Noradrenergic mechanisms in the prefrontal cortex.
@en
prefLabel
Noradrenergic mechanisms in the prefrontal cortex.
@en
P2093
P2860
P1476
Noradrenergic mechanisms in the prefrontal cortex.
@en
P2093
P2860
P304
P356
10.1177/026988119701100209
P407
P577
1997-01-01T00:00:00Z